These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26150100)

  • 1. Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?
    Kassimis G; Davlouros P; Patel N; De Maria G; Kallistratos MS; Kharbanda RK; Manolis AJ; Alexopoulos D; Banning AP
    Cardiovasc Drugs Ther; 2015; 29(5):481-93. PubMed ID: 26150100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adenosine as adjunctive therapy in acute myocardial infarction.
    Forman MB; Stone GW; Jackson EK
    Cardiovasc Drug Rev; 2006; 24(2):116-47. PubMed ID: 16961725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
    Quintana M; Kahan T; Hjemdahl P
    Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials.
    Bulluck H; Sirker A; Loke YK; Garcia-Dorado D; Hausenloy DJ
    Int J Cardiol; 2016 Jan; 202():228-37. PubMed ID: 26402450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and physical prevention and treatment of no-reflow after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Guo AQ; Sheng L; Lei X; Shu W
    J Int Med Res; 2013 Jun; 41(3):537-47. PubMed ID: 23628920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological approaches to reperfusion therapy.
    Morel O; Perret T; Delarche N; Labèque JN; Jouve B; Elbaz M; Piot C; Ovize M
    Cardiovasc Res; 2012 May; 94(2):246-52. PubMed ID: 22514248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
    Chakrabarti AK; Feeney K; Abueg C; Brown DA; Czyz E; Tendera M; Janosi A; Giugliano RP; Kloner RA; Weaver WD; Bode C; Godlewski J; Merkely B; Gibson CM
    Am Heart J; 2013 Apr; 165(4):509-514.e7. PubMed ID: 23537966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction.
    Zhang H; Tian NL; Hu ZY; Wang F; Chen L; Zhang YJ; Chen SL
    Chin Med J (Engl); 2012 May; 125(10):1713-9. PubMed ID: 22800889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
    Monassier JP
    Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury.
    Fordyce CB; Gersh BJ; Stone GW; Granger CB
    Trends Pharmacol Sci; 2015 Sep; 36(9):605-16. PubMed ID: 26148636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac protection during acute myocardial infarction: where do we stand in 2004?
    Kloner RA; Rezkalla SH
    J Am Coll Cardiol; 2004 Jul; 44(2):276-86. PubMed ID: 15261919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine for myocardial protection in acute myocardial infarction.
    Granger CB
    Am J Cardiol; 1997 Jun; 79(12A):44-8. PubMed ID: 9223363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
    Ishihara M; Asakura M; Kimura K; Nakao K; Hamada C; Hirayama A
    J Cardiol; 2014 Jan; 63(1):82-7. PubMed ID: 23860273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State of the science of cardioprotection: Challenges and opportunities--proceedings of the 2010 NHLBI Workshop on Cardioprotection.
    Kloner RA; Schwartz Longacre L
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):223-32. PubMed ID: 21821520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of tissue perfusion in ST segment elevation myocardial infarction patients undergoing reperfusion strategies: role of adenosine.
    Forman MB; Jackson EK
    Clin Cardiol; 2007 Nov; 30(11):583-5. PubMed ID: 18000974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC; Reiter RJ; Jimenez-Sosa A
    Contemp Clin Trials; 2007 Jul; 28(4):532-9. PubMed ID: 17123867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
    Alfayoumi F; Srinivasan V; Geller M; Gradman A
    Rev Cardiovasc Med; 2005; 6(2):72-83. PubMed ID: 15976730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.